Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 376

1.

Increased low density lipoprotein and increased likelihood of positive prostate biopsy in black americans.

Moses KA, Abd TT, Goodman M, Hsiao W, Hall JA, Marshall FF, Petros JA, Issa MM.

J Urol. 2009 Nov;182(5):2219-25. doi: 10.1016/j.juro.2009.07.039. Epub 2009 Sep 16.

PMID:
19758611
[PubMed - indexed for MEDLINE]
2.

Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.

Henderson RJ, Eastham JA, Culkin DJ, Kattan MW, Whatley T, Mata J, Venable D, Sartor O.

J Natl Cancer Inst. 1997 Jan 15;89(2):134-8.

PMID:
8998182
[PubMed - indexed for MEDLINE]
Free Article
3.

Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.

Fowler JE Jr, Bigler SA, Kilambi NK, Land SA.

Urology. 1999 Jun;53(6):1175-8.

PMID:
10367848
[PubMed - indexed for MEDLINE]
4.

Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black american men but not in white men: results from a consecutive series of 914 men.

Latchamsetty KC, Kim J, Porter CR.

J Urol. 2006 Mar;175(3 Pt 1):913-7; discussion 917.

PMID:
16469578
[PubMed - indexed for MEDLINE]
5.

Is race a positive predictor of cancer on repeat prostate biopsy?

Yanke BV, Salzhauer EW, Colon I.

J Urol. 2006 Sep;176(3):1114-7.

PMID:
16890704
[PubMed - indexed for MEDLINE]
6.

Prostate cancer detection in Black and White men with abnormal digital rectal examination and prostate specific antigen less then 4 ng./ml.

Fowler JE JR, Bigler SA, Farabaugh PB, Wilson SS.

J Urol. 2000 Dec;164(6):1961-3.

PMID:
11061891
[PubMed - indexed for MEDLINE]
7.

The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.

Pruthi RS, Swords K, Schultz H, Carson CC 3rd, Wallen EM.

J Urol. 2009 Feb;181(2):574-7; discussion 578. doi: 10.1016/j.juro.2008.10.028. Epub 2008 Dec 13.

PMID:
19084847
[PubMed - indexed for MEDLINE]
8.

Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer.

Reed A, Ankerst DP, Pollock BH, Thompson IM, Parekh DJ.

J Urol. 2007 Nov;178(5):1929-32; discussion 1932. Epub 2007 Sep 17.

PMID:
17868724
[PubMed - indexed for MEDLINE]
9.

Racial variations in the performance of prostate specific antigen and prostate specific antigen density in the era of extended prostate biopsy schemes.

Elliott CS, Shinghal R, Presti JC Jr.

J Urol. 2008 Oct;180(4):1318-23; discussion 1323-4. doi: 10.1016/j.juro.2008.06.031. Epub 2008 Aug 15.

PMID:
18707710
[PubMed - indexed for MEDLINE]
10.

Clinical characteristics in black and white men with prostate cancer in an equal access medical center.

Freedland SJ, Sutter ME, Naitoh J, Dorey F, Csathy GS, Aronson WJ.

Urology. 2000 Mar;55(3):387-90.

PMID:
10699616
[PubMed - indexed for MEDLINE]
11.

Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer.

Kubricht WS, Kattan MW, Sartor O, Eastham JA.

Urology. 1999 Mar;53(3):553-6.

PMID:
10096383
[PubMed - indexed for MEDLINE]
12.

Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.

Loeb S, Nadler RB, Roehl KA, Antenor JA, Catalona WJ.

J Urol. 2007 May;177(5):1745-8.

PMID:
17437803
[PubMed - indexed for MEDLINE]
13.

Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy.

Antonelli JA, Jones LW, BaƱez LL, Thomas JA, Anderson K, Taylor LA, Gerber L, Anderson T, Hoyo C, Grant D, Freedland SJ.

J Urol. 2009 Nov;182(5):2226-31. doi: 10.1016/j.juro.2009.07.028. Epub 2009 Sep 16.

PMID:
19758620
[PubMed - indexed for MEDLINE]
14.

Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.

Tan N, Lane BR, Li J, Moussa AS, Soriano M, Jones JS.

J Urol. 2008 Oct;180(4):1325-9; discussion 1329. doi: 10.1016/j.juro.2008.06.022. Epub 2008 Aug 15.

PMID:
18707706
[PubMed - indexed for MEDLINE]
15.

The influence of statin medications on prostate-specific antigen levels.

Hamilton RJ, Goldberg KC, Platz EA, Freedland SJ.

J Natl Cancer Inst. 2008 Nov 5;100(21):1511-8. doi: 10.1093/jnci/djn362. Epub 2008 Oct 28.

PMID:
18957682
[PubMed - indexed for MEDLINE]
Free Article
16.

Molecular markers and death from prostate cancer.

Concato J, Jain D, Uchio E, Risch H, Li WW, Wells CK.

Ann Intern Med. 2009 May 5;150(9):595-603.

PMID:
19414838
[PubMed - indexed for MEDLINE]
17.

Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy.

Mitin T, Chen MH, Zhang Y, Moran BJ, Dosoretz DE, Katin MJ, Braccioforte MH, Salenius SA, D'Amico AV.

J Urol. 2011 Dec;186(6):2233-7. doi: 10.1016/j.juro.2011.07.072. Epub 2011 Oct 22.

PMID:
22019035
[PubMed - indexed for MEDLINE]
18.

Is low serum free testosterone a marker for high grade prostate cancer?

Hoffman MA, DeWolf WC, Morgentaler A.

J Urol. 2000 Mar;163(3):824-7.

PMID:
10687985
[PubMed - indexed for MEDLINE]
19.

Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.

Chamie K, DeVere White RW, Lee D, Ok JH, Ellison LM.

Cancer. 2008 Nov 1;113(9):2464-70. doi: 10.1002/cncr.23695.

PMID:
18666213
[PubMed - indexed for MEDLINE]
Free Article
20.

Body mass index as a predictor of prostate cancer: development versus detection on biopsy.

Freedland SJ, Terris MK, Platz EA, Presti JC Jr.

Urology. 2005 Jul;66(1):108-13.

PMID:
15992911
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk